| Overview |
| bsm-90001r-50µL |
| ACAP2 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ACAP2 |
| 650-720/778 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 23527 |
| Q15057 |
| ACAP2; ArfGAP With Coiled-Coil Ankyrin Repeat And PH Domains 2; KIAA0041; CNT-B2; CENTB2; Arf-GAP With Coiled-Coil ANK Repeat And PH Domain-Containing Protein 2; Centaurin-Beta-2; Arf GAP With Coiled Coil ANK Repeat And PH Domains 2; Centaurin Beta 2; Cnt-B2 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |